By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300




Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Amersham Biosciences 

Bristol-Myers Squibb 

PanVera LLC 


Massachusetts Life Sciences Center 

Company News
Pennsylvania Judge Reverses Johnson & Johnson (JNJ)'s Pelvic Mesh Win 7/27/2017 7:53:09 AM
Bavarian Nordic (BAVA.CO) Rockets on Expanded $846 Million HIV-Hepatitis B Deal With Johnson & Johnson (JNJ) 7/27/2017 6:26:14 AM
Johnson & Johnson (JNJ) Rolls Pulsar Vascular and Neuravi Acquisitions Into a New Neurovascular Biz Dubbed Cerenovus 7/25/2017 7:22:29 AM
AbbVie (ABBV), Eli Lilly (LLY) and Johnson & Johnson (JNJ) Get in on Rodeo Therapeutics' Series A Funding Round 7/25/2017 6:16:27 AM
Johnson & Johnson (JNJ) Announces Encouraging First-In-Human Clinical Data For Investigational HIV Preventive Vaccine 7/24/2017 7:46:12 AM
5 Off-The-Radar Numbers To Take Note Of In Johnson & Johnson (JNJ)'s Second-Quarter Report 7/20/2017 6:35:20 AM
Johnson & Johnson (JNJ) Reports 2017 Second-Quarter Results 7/18/2017 10:00:46 AM
Johnson & Johnson (JNJ) Announces Quarterly Dividend For Third Quarter 2017 7/17/2017 10:20:28 AM
FDA Gives Nod to Johnson & Johnson (JNJ)'s Potential Blockbuster Psoriasis Med 7/14/2017 5:51:38 AM
Why Eli Lilly (LLY) Is Gouging Diabetes Drug Share From Dow's Johnson & Johnson (JNJ), Others 7/11/2017 7:07:08 AM